BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 28176204)

  • 21. Preoperative Screening of Colorectal Cancers Is As Accurate As Postoperative Screening for Detection of Lynch Syndrome.
    Harrigan J; Davis C; Chauhan M; Buckles D; Saeed A; Kennedy K; Collins DL; Olyaee M; Madan R; Bansal A
    Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2372-2374.e1. PubMed ID: 32428707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of patients at-risk for Lynch syndrome in a hospital-based colorectal surgery clinic.
    Koehler-Santos P; Izetti P; Abud J; Pitroski CE; Cossio SL; Camey SA; Tarta C; Damin DC; Contu PC; Rosito MA; Ashton-Prolla P; Prolla JC
    World J Gastroenterol; 2011 Feb; 17(6):766-73. PubMed ID: 21390147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Prospective Six Sigma Quality Improvement Trial to Optimize Universal Screening for Genetic Syndrome Among Patients With Young-Onset Colorectal Cancer.
    Dineen S; Lynch PM; Rodriguez-Bigas MA; Bannon S; Taggart M; Reeves C; Modaro C; Overman M; Chang GJ; Skibber JM; You YN
    J Natl Compr Canc Netw; 2015 Jul; 13(7):865-72. PubMed ID: 26150580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer screening behaviors and risk perceptions among family members of colorectal cancer patients with unexplained mismatch repair deficiency.
    Katz LH; Advani S; Burton-Chase AM; Fellman B; Polivka KM; Yuan Y; Lynch PM; Peterson SK
    Fam Cancer; 2017 Apr; 16(2):231-237. PubMed ID: 27832499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome.
    Watkins JC; Yang EJ; Muto MG; Feltmate CM; Berkowitz RS; Horowitz NS; Syngal S; Yurgelun MB; Chittenden A; Hornick JL; Crum CP; Sholl LM; Howitt BE
    Int J Gynecol Pathol; 2017 Mar; 36(2):115-127. PubMed ID: 27556954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome.
    van Lier MG; Leenen CH; Wagner A; Ramsoekh D; Dubbink HJ; van den Ouweland AM; Westenend PJ; de Graaf EJ; Wolters LM; Vrijland WW; Kuipers EJ; van Leerdam ME; Steyerberg EW; Dinjens WN;
    J Pathol; 2012 Apr; 226(5):764-74. PubMed ID: 22081473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Management of hereditary non-polyposis syndrome (Lynch syndrome)].
    Kariv R; Goldberg Y; Soler I; Rosner G; Half E; Moshkowitz M; Vilkin A; Levi Z; Niv Y
    Harefuah; 2011 Apr; 150(4):392-6, 416. PubMed ID: 22164924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tumour examination to detect hereditary colorectal cancer].
    Hoogerbrugge N; Hermens RP; Nagengast F; Overbeek L; van Krieken HJ; Ligtenberg M
    Ned Tijdschr Geneeskd; 2012; 156(42):A4982. PubMed ID: 23075775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lynch Syndrome: Current management In 2019.
    Menahem B; Alves A; Regimbeau JM; Sabbagh C
    J Visc Surg; 2019 Dec; 156(6):507-514. PubMed ID: 31445799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suboptimal Adherence in Clinical Practice to Guidelines Recommendation to Screen for Lynch Syndrome.
    Jain A; Shafer L; Rothenmund H; Kim CA; Samadder J; Gupta S; Singh H
    Dig Dis Sci; 2019 Dec; 64(12):3489-3501. PubMed ID: 31187321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population-Based Lynch Syndrome Screening by Microsatellite Instability in Patients ≤50: Prevalence, Testing Determinants, and Result Availability Prior to Colon Surgery.
    Karlitz JJ; Hsieh MC; Liu Y; Blanton C; Schmidt B; Jessup JM; Wu XC; Chen VW
    Am J Gastroenterol; 2015 Jul; 110(7):948-55. PubMed ID: 25601013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Which Lynch syndrome screening programs could be implemented in the "real world"? A systematic review of economic evaluations.
    Di Marco M; DAndrea E; Panic N; Baccolini V; Migliara G; Marzuillo C; De Vito C; Pastorino R; Boccia S; Villari P
    Genet Med; 2018 Oct; 20(10):1131-1144. PubMed ID: 29300371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population-based screening for Lynch syndrome in Western Australia.
    Schofield L; Grieu F; Amanuel B; Carrello A; Spagnolo D; Kiraly C; Pachter N; Goldblatt J; Platell C; Levitt M; Stewart C; Salama P; Ee H; Raftopoulous S; Katris P; Threlfall T; Edkins E; Wallace M; Iacopetta B
    Int J Cancer; 2014 Sep; 135(5):1085-91. PubMed ID: 24474394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-Effectiveness Analysis of Different Genetic Testing Strategies for Lynch Syndrome in Taiwan.
    Chen YE; Kao SS; Chung RH
    PLoS One; 2016; 11(8):e0160599. PubMed ID: 27482709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Underutilization of microsatellite instability analysis in colorectal cancer patients at high risk for Lynch syndrome.
    Van Lier MG; De Wilt JH; Wagemakers JJ; Dinjens WN; Damhuis RA; Wagner A; Kuipers EJ; Van Leerdam ME
    Scand J Gastroenterol; 2009; 44(5):600-4. PubMed ID: 19153873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
    Carethers JM; Stoffel EM
    World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center.
    Moline J; Mahdi H; Yang B; Biscotti C; Roma AA; Heald B; Rose PG; Michener C; Eng C
    Gynecol Oncol; 2013 Jul; 130(1):121-6. PubMed ID: 23612316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Swiss cost-effectiveness analysis of universal screening for Lynch syndrome of patients with colorectal cancer followed by cascade genetic testing of relatives.
    Salikhanov I; Heinimann K; Chappuis P; Buerki N; Graffeo R; Heinzelmann V; Rabaglio M; Taborelli M; Wieser S; Katapodi MC
    J Med Genet; 2022 Sep; 59(9):924-930. PubMed ID: 34782441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population-based molecular screening for Lynch syndrome: implications for personalized medicine.
    Ward RL; Hicks S; Hawkins NJ
    J Clin Oncol; 2013 Jul; 31(20):2554-62. PubMed ID: 23733757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Universal tumor screening for lynch syndrome: perspectives of patients regarding willingness and informed consent.
    Subramonian A; Smith D; Dicks E; Dawson L; Borgaonkar M; Etchegary H
    Per Med; 2020 Sep; 17(5):373-387. PubMed ID: 32875945
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.